Guselkumab用于治疗坏疽性脓皮病

JEADV clinical practice Pub Date : 2024-09-30 DOI:10.1002/jvc2.547

Sera Sarsam, Holly Sexton, Jenny Nicolopoulos, Con Dolianitis

{"title":"Guselkumab用于治疗坏疽性脓皮病","authors":"Sera Sarsam, Holly Sexton, Jenny Nicolopoulos, Con Dolianitis","doi":"10.1002/jvc2.547","DOIUrl":null,"url":null,"abstract":"<p>Pyoderma gangrenosum (PG) is a complex disease with limited therapeutic options. Here we report the use of higher dose of guselkumab, a monoclonal antibody targeting interleukin (IL-) 23, in the treatment of PG in a medically complex patient. This case contributes additional evidence supporting the potential effectiveness of guselkumab in the treatment of PG and highlights the necessity for larger studies to confirm these findings.</p>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 1","pages":"240-243"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.547","citationCount":"0","resultStr":"{\"title\":\"Guselkumab for the treatment of pyoderma gangrenosum\",\"authors\":\"Sera Sarsam, Holly Sexton, Jenny Nicolopoulos, Con Dolianitis\",\"doi\":\"10.1002/jvc2.547\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Pyoderma gangrenosum (PG) is a complex disease with limited therapeutic options. Here we report the use of higher dose of guselkumab, a monoclonal antibody targeting interleukin (IL-) 23, in the treatment of PG in a medically complex patient. This case contributes additional evidence supporting the potential effectiveness of guselkumab in the treatment of PG and highlights the necessity for larger studies to confirm these findings.</p>\",\"PeriodicalId\":94325,\"journal\":{\"name\":\"JEADV clinical practice\",\"volume\":\"4 1\",\"pages\":\"240-243\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.547\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JEADV clinical practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jvc2.547\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JEADV clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jvc2.547","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

坏疽性脓皮病是一种复杂的疾病，治疗方法有限。在这里，我们报告使用高剂量的guselkumab，一种针对白细胞介素（IL-） 23的单克隆抗体，在治疗PG的医学复杂的病人。该病例提供了额外的证据，支持guselkumab治疗PG的潜在有效性，并强调需要进行更大规模的研究来证实这些发现。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Guselkumab for the treatment of pyoderma gangrenosum

查看原文本刊更多论文

Guselkumab for the treatment of pyoderma gangrenosum

Pyoderma gangrenosum (PG) is a complex disease with limited therapeutic options. Here we report the use of higher dose of guselkumab, a monoclonal antibody targeting interleukin (IL-) 23, in the treatment of PG in a medically complex patient. This case contributes additional evidence supporting the potential effectiveness of guselkumab in the treatment of PG and highlights the necessity for larger studies to confirm these findings.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JEADV clinical practice

CiteScore

0.30

自引率

0.00%

发文量